Exelixis, Inc. (EX9.DE)
EUR 32.28
(1.22%)
EUR 32.28
(1.22%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.75 Billion USD | 13.17% |
| 2022 | 1.55 Billion USD | 12.38% |
| 2021 | 1.38 Billion USD | 45.29% |
| 2020 | 951.26 Million USD | 1.77% |
| 2019 | 934.67 Million USD | 12.96% |
| 2018 | 827.47 Million USD | 89.18% |
| 2017 | 437.41 Million USD | 136.56% |
| 2016 | 184.9 Million USD | 455.65% |
| 2015 | 33.27 Million USD | 44.26% |
| 2014 | 23.06 Million USD | -23.67% |
| 2013 | 30.22 Million USD | -36.31% |
| 2012 | 47.45 Million USD | -83.62% |
| 2011 | 289.63 Million USD | 56.52% |
| 2010 | 185.04 Million USD | 21.93% |
| 2009 | 151.75 Million USD | 28.76% |
| 2008 | 117.85 Million USD | 3.87% |
| 2007 | 113.47 Million USD | 15.0% |
| 2006 | 98.67 Million USD | 29.9% |
| 2005 | 75.96 Million USD | 43.71% |
| 2004 | 52.85 Million USD | 2.56% |
| 2003 | 51.54 Million USD | 16.29% |
| 2002 | 44.32 Million USD | 8.09% |
| 2001 | 41 Million USD | -5.42% |
| 2000 | 43.35 Million USD | 167.63% |
| 1999 | 16.2 Million USD | 613.03% |
| 1998 | 2.27 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 403.97 Million USD | -11.78% |
| 2023 FY | 1.75 Billion USD | 13.17% |
| 2023 Q3 | 453.14 Million USD | 0.22% |
| 2023 Q2 | 452.14 Million USD | 14.62% |
| 2023 Q1 | 394.47 Million USD | -3.31% |
| 2023 Q4 | 457.89 Million USD | 1.05% |
| 2022 Q4 | 407.99 Million USD | 2.92% |
| 2022 Q3 | 396.43 Million USD | -2.34% |
| 2022 Q2 | 405.94 Million USD | 18.43% |
| 2022 Q1 | 342.77 Million USD | -21.78% |
| 2022 FY | 1.55 Billion USD | 12.38% |
| 2021 FY | 1.38 Billion USD | 45.29% |
| 2021 Q3 | 316.54 Million USD | -14.51% |
| 2021 Q2 | 370.29 Million USD | 44.06% |
| 2021 Q1 | 257.03 Million USD | -1.53% |
| 2021 Q4 | 438.22 Million USD | 38.44% |
| 2020 Q1 | 217.62 Million USD | -5.29% |
| 2020 Q2 | 250.25 Million USD | 14.99% |
| 2020 Q3 | 222.36 Million USD | -11.14% |
| 2020 Q4 | 261.01 Million USD | 17.38% |
| 2020 FY | 951.26 Million USD | 1.77% |
| 2019 Q2 | 232.73 Million USD | 11.9% |
| 2019 FY | 934.67 Million USD | 12.96% |
| 2019 Q4 | 229.79 Million USD | -13.01% |
| 2019 Q3 | 264.16 Million USD | 13.5% |
| 2019 Q1 | 207.98 Million USD | -6.0% |
| 2018 Q1 | 206.7 Million USD | 78.38% |
| 2018 Q4 | 221.25 Million USD | 1.47% |
| 2018 FY | 827.47 Million USD | 89.18% |
| 2018 Q2 | 180.11 Million USD | -12.87% |
| 2018 Q3 | 218.03 Million USD | 21.06% |
| 2017 Q3 | 147.85 Million USD | 54.02% |
| 2017 Q2 | 95.99 Million USD | 23.57% |
| 2017 Q4 | 115.88 Million USD | -21.62% |
| 2017 FY | 437.41 Million USD | 136.56% |
| 2017 Q1 | 77.68 Million USD | 2.58% |
| 2016 Q4 | 75.72 Million USD | 26.77% |
| 2016 Q2 | 34.69 Million USD | 135.33% |
| 2016 Q1 | 14.74 Million USD | 65.36% |
| 2016 Q3 | 59.73 Million USD | 72.2% |
| 2016 FY | 184.9 Million USD | 455.65% |
| 2015 Q3 | 8.43 Million USD | 15.44% |
| 2015 Q2 | 7.3 Million USD | -15.26% |
| 2015 Q1 | 8.62 Million USD | 29.28% |
| 2015 FY | 33.27 Million USD | 44.26% |
| 2015 Q4 | 8.91 Million USD | 5.7% |
| 2014 FY | 23.06 Million USD | -23.67% |
| 2014 Q4 | 6.66 Million USD | 16.63% |
| 2014 Q3 | 5.71 Million USD | -6.03% |
| 2014 Q2 | 6.08 Million USD | 32.4% |
| 2014 Q1 | 4.59 Million USD | 12.54% |
| 2013 Q3 | 5.17 Million USD | -55.27% |
| 2013 Q2 | 11.57 Million USD | 23.24% |
| 2013 FY | 30.22 Million USD | -36.31% |
| 2013 Q1 | 9.38 Million USD | 20.16% |
| 2013 Q4 | 4.08 Million USD | -21.1% |
| 2012 Q4 | 7.81 Million USD | -41.31% |
| 2012 FY | 47.45 Million USD | -83.62% |
| 2012 Q1 | 18.51 Million USD | -80.16% |
| 2012 Q2 | 7.81 Million USD | -57.79% |
| 2012 Q3 | 13.31 Million USD | 70.4% |
| 2011 FY | 289.63 Million USD | 56.52% |
| 2011 Q1 | 35.89 Million USD | -11.98% |
| 2011 Q2 | 32.16 Million USD | -10.39% |
| 2011 Q3 | 128.27 Million USD | 298.83% |
| 2011 Q4 | 93.3 Million USD | -27.26% |
| 2010 Q4 | 40.77 Million USD | -25.15% |
| 2010 Q1 | 42.19 Million USD | -4.26% |
| 2010 FY | 185.04 Million USD | 21.93% |
| 2010 Q2 | 47.59 Million USD | 12.79% |
| 2010 Q3 | 54.47 Million USD | 14.45% |
| 2009 Q1 | 25.3 Million USD | -14.44% |
| 2009 Q4 | 44.07 Million USD | -19.82% |
| 2009 Q3 | 54.97 Million USD | 100.63% |
| 2009 Q2 | 27.4 Million USD | 8.3% |
| 2009 FY | 151.75 Million USD | 28.76% |
| 2008 Q2 | 30.41 Million USD | 8.83% |
| 2008 Q1 | 27.94 Million USD | -4.46% |
| 2008 FY | 117.85 Million USD | 3.87% |
| 2008 Q4 | 29.57 Million USD | -1.2% |
| 2008 Q3 | 29.93 Million USD | -1.58% |
| 2007 Q2 | 29.25 Million USD | 3.99% |
| 2007 Q3 | 26.82 Million USD | -8.32% |
| 2007 Q1 | 28.13 Million USD | -5.49% |
| 2007 Q4 | 29.25 Million USD | 9.04% |
| 2007 FY | 113.47 Million USD | 15.0% |
| 2006 Q2 | 27.24 Million USD | 50.34% |
| 2006 Q4 | 29.77 Million USD | 26.47% |
| 2006 Q3 | 23.54 Million USD | -13.58% |
| 2006 Q1 | 18.11 Million USD | 26.03% |
| 2006 FY | 98.67 Million USD | 29.9% |
| 2005 Q1 | 12.87 Million USD | -18.23% |
| 2005 Q4 | 14.37 Million USD | -0.16% |
| 2005 FY | 75.96 Million USD | 43.71% |
| 2005 Q2 | 34.31 Million USD | 166.51% |
| 2005 Q3 | 14.4 Million USD | -58.03% |
| 2004 FY | 52.85 Million USD | 2.56% |
| 2004 Q3 | 12.66 Million USD | 0.82% |
| 2004 Q4 | 15.74 Million USD | 24.34% |
| 2004 Q2 | 12.55 Million USD | 5.61% |
| 2004 Q1 | 11.89 Million USD | -13.61% |
| 2003 Q4 | 13.76 Million USD | 10.67% |
| 2003 Q3 | 12.43 Million USD | -4.35% |
| 2003 Q2 | 13 Million USD | 5.47% |
| 2003 Q1 | 12.33 Million USD | -0.99% |
| 2003 FY | 51.54 Million USD | 16.29% |
| 2002 FY | 44.32 Million USD | 8.09% |
| 2002 Q4 | 12.45 Million USD | 19.4% |
| 2002 Q3 | 10.43 Million USD | 5.39% |
| 2002 Q2 | 9.89 Million USD | -14.39% |
| 2002 Q1 | 11.56 Million USD | -9.64% |
| 2001 Q4 | 12.79 Million USD | 7.25% |
| 2001 FY | 41 Million USD | -5.42% |
| 2001 Q2 | 8.55 Million USD | -9.78% |
| 2001 Q1 | 9.47 Million USD | -10.46% |
| 2001 Q3 | 11.92 Million USD | 39.49% |
| 2000 Q3 | 10.89 Million USD | -8.24% |
| 2000 FY | 43.35 Million USD | 167.63% |
| 2000 Q1 | 9.99 Million USD | 0.0% |
| 2000 Q2 | 11.87 Million USD | 18.78% |
| 2000 Q4 | 10.58 Million USD | -2.86% |
| 1999 FY | 16.2 Million USD | 613.03% |
| 1998 FY | 2.27 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| BioNTech SE | 3.21 Billion EUR | 45.401% |
| CureVac N.V. | -70.6 Million EUR | 2589.323% |
| Biotest Aktiengesellschaft | 271.9 Million EUR | -546.437% |
| Biotest Aktiengesellschaft | 271.9 Million EUR | -546.437% |
| BRAIN Biotech AG | 30.12 Million EUR | -5735.14% |
| Formycon AG | 23.3 Million EUR | -7441.991% |
| Heidelberg Pharma AG | 6.6 Million EUR | -26506.701% |
| Medigene AG | 4.39 Million EUR | -39928.718% |